Process View
An immune response which is associated with resistance to intracellular bacteria, fungi, and protozoa, and pathological conditions such as arthritis, and which is typically orchestrated by the production of particular cytokines by T-helper 1 cells, most notably interferon-gamma, IL-2, and lymphotoxin.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "t helper 1 type immune response"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.855 | ||
HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.844 | ||
HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.809 | ||
HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.809 | ||
NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.783 | ||
HLA-DMB | major histocompatibility complex, class II, DM beta | 0.707 | ||
NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.679 | ||
RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.637 | Mouse | |
IL4R | interleukin 4 receptor | 0.623 | Mouse | |
BCL3 | B-cell CLL/lymphoma 3 | 0.579 | Mouse | |
HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.544 | Human | |
TRAF1 | TNF receptor-associated factor 1 | 0.496 | ||
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.228 | ||
IL2RG | interleukin 2 receptor, gamma | 0.204 | ||
HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.133 | ||
BIRC3 | baculoviral IAP repeat containing 3 | 0.129 | ||
IL4 | interleukin 4 | 0.107 | Mouse | |
TAB2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | 0.088 | ||
REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.088 | ||
NRP1 | neuropilin 1 | 0.083 | ||
HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.081 | ||
HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.065 | ||
HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.064 | ||
CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.059 | ||
TRAF3 | TNF receptor-associated factor 3 | 0.052 | ||
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.050 | ||
HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.040 | Human Mouse | |
IRAK2 | interleukin-1 receptor-associated kinase 2 | 0.037 | ||
TAB3 | TGF-beta activated kinase 1/MAP3K7 binding protein 3 | 0.033 | ||
TNIP2 | TNFAIP3 interacting protein 2 | 0.029 | ||
NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.028 | ||
PLXND1 | plexin D1 | 0.027 | ||
MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.024 | ||
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.019 | ||
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.015 | ||
CCR7 | chemokine (C-C motif) receptor 7 | 0.012 | ||
SOCS3 | suppressor of cytokine signaling 3 | 0.012 | ||
IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | 0.011 | ||
BCL10 | B-cell CLL/lymphoma 10 | 0.010 | ||
NOD2 | nucleotide-binding oligomerization domain containing 2 | 0.010 |